Description

1-Myristoyl-2-(11-(4,4-Dimethyl-3-Oxy-2-Ethyl-2-Oxazolidinyl)Undecanoyl)-Sn-Glycero-3-Phosphocholine is a high-purity, synthetic phospholipid derivative, specifically engineered for advanced research and pharmaceutical development. This compound is valued for its role as a key intermediate and functional component in the formulation of lipid-based drug delivery systems, such as liposomes and lipid nanoparticles. It is essential for researchers and manufacturers in the pharmaceutical, biotechnology, and advanced materials sectors who require precise, well-characterized lipids for targeted drug delivery, diagnostic imaging, and membrane biology studies.

Application

• Liposome and Lipid Nanoparticle (LNP) Formulation: A critical building block for creating stable, targeted drug delivery vehicles for mRNA, siRNA, and small molecule therapeutics.
• Pharmaceutical Research & Development: Used as a specialized excipient or active targeting ligand in preclinical and clinical-stage nanomedicine development.
• Membrane Biophysics Studies: Employed to synthesize model membranes for studying protein-lipid interactions, membrane fluidity, and cellular uptake mechanisms.
• Diagnostic Agent Carrier: Incorporated into contrast agent formulations for medical imaging techniques like MRI and ultrasound.
• Gene Therapy Vectors: A component in non-viral vector systems designed for efficient and safe nucleic acid delivery.
• Cosmetic & Dermal Delivery Systems: Used in advanced cosmetic formulations for the encapsulation and enhanced skin penetration of active ingredients.

Basic Information

Product Name	1-Myristoyl-2-(11-(4,4-Dimethyl-3-Oxy-2-Ethyl-2-Oxazolidinyl)Undecanoyl)-Sn-Glycero-3-Phosphocholine
CAS No.	132885-46-2
Molecular Formula	C₄₀H₇₉N₂O₉P
Molecular Weight	763.04 g/mol
Synonyms	1-Myristoyl-2-{11-[(4,4-dimethyl-2-ethyl-3-oxo-1,3-oxazolidin-2-yl)]undecanoyl}-sn-glycero-3-phosphocholine; PC(14:0/11-DMOE); Phosphatidylcholine, 1-tetradecanoyl-2-[11-[(4,4-dimethyl-2-ethyl-3-oxo-2-oxazolidinyl)]undecanoyl]-; DMOE-PC; 1-Myristoyl-2-(DMOE-undecanoyl)-sn-glycero-3-phosphocholine; Fluorescent Phospholipid Analog (DMOE-labeled); 2-{11-[(2-Ethyl-4,4-dimethyl-3-oxo-1,3-oxazolidin-2-yl)]undecanoyl}-1-tetradecanoyl-sn-glycero-3-phosphocholine
EINECS	Contact for details

Quality Control

Our 1-Myristoyl-2-(11-(4,4-Dimethyl-3-Oxy-2-Ethyl-2-Oxazolidinyl)Undecanoyl)-Sn-Glycero-3-Phosphocholine is manufactured under strict quality management systems. Each batch undergoes comprehensive analytical testing, including HPLC for purity and identity confirmation, to ensure it meets the stringent requirements for pharmaceutical research and development. A detailed Certificate of Analysis (COA) is provided with every shipment, documenting critical quality attributes. We support compliance with cGMP and ISO 9001 standards for traceability and consistency.

Storage

Preserve in a tightly closed container, protected from light. Store at -20°C or below under an inert atmosphere (e.g., argon or nitrogen) due to its hygroscopic and moisture-sensitive nature. For long-term storage, desiccate. Allow the sealed container to reach room temperature before opening to prevent condensation and moisture ingress.

Specification

Item	Specification
Appearance	White to off-white solid or waxy solid
Identification (HPLC/MS)	Conforms to reference standard
Identification (NMR)	Conforms to structure
Purity (HPLC)	≥ 95% (Area %)
Assay	≥ 98% (by Phosphorus Analysis)
Solubility	Soluble in chloroform, methanol, DMSO; slightly soluble in ethanol
Water Content (KF)	≤ 1.0 %
Residual Solvents (GC)	Meets ICH guidelines

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.